i-manager Publications

AI for the Detection of Neurological Condition: Parkinson's Disease & Emotions

Abhishek Jain*, Rohit Raja**

*-** Central University, Bilaspur, India.

Periodicity:January - June'2023
DOI : https://doi.org/10.26634/jaim.1.1.19135

Abstract

Artificial Intelligence (AI) is widely applied by many researchers in the measurement and analysis of signals and images in clinical medicine and the biological sciences. The role of machine learning in processing biomedical signals and its applications in medicine and healthcare is huge, and it is now in a very advanced stage. Several types of biomedical signals have been analyzed by using Deep Learning (DL), Neural Networks (NN), and Artificial Intelligence on Electrocardiogram (ECG) and Electroencephalogram (EEG) signals by many researchers. Parkinson's disease (PD) is a neurodegenerative disorder that progresses over time and is characterized by rigidity, tremor, postural instability, and non-motor symptoms caused by the loss of dopaminergic neurons in the substantia nigra. This paper analyses the current state of the art of EEG analysis using AI techniques for Parkinson's disease detection and emotion detection.

Keywords

Artificial Intelligence (AI), EEG, Parkinson's Disease (PD), Emotion Detection.

How to Cite this Article?

Jain, A., and Raja, R. (2023). AI for the Detection of Neurological Condition: Parkinson's Disease & Emotions. i-manager’s Journal on Artificial Intelligence & Machine Learning, 1(1), 34-40. https://doi.org/10.26634/jaim.1.1.19135

References

[1]. Anjum, M. F., Dasgupta, S., Mudumbai, R., Singh, A., Cavanagh, J. F., & Narayanan, N. S. (2020). Linear predictive coding distinguishes spectral EEG features of Parkinson's disease. Parkinsonism & Related Disorders, 79, 79-85.

[2]. Chaturvedi, M., Hatz, F., Gschwandtner, U., Bogaarts, J. G., Meyer, A., Fuhr, P., & Roth, V. (2017). Quantitative EEG (QEEG) measures differentiate Parkinson's disease (PD) patients from healthy controls (HC). Frontiers in Aging Neuroscience, 9, 3.

[3]. Chaudhuri, K. R., & Schapira, A. H. (2009). Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. The Lancet Neurology, 8(5), 464-474.

[4]. De Oliveira, A. P. S., De Santana, M. A., Andrade, M. K. S., Gomes, J. C., Rodrigues, M. C., & dos Santos, W. P. (2020). Early diagnosis of Parkinson's disease using EEG, machine learning and partial directed coherence. Research on Biomedical Engineering, 36, 311-331.

[5]. Drissi, T. B., Zayrit, S., Nsiri, B., & Ammoummou, A. (2019). Diagnosis of Parkinson's disease based on wavelet transform and Mel frequency cepstral coefficients. International Journal of Advanced Computer Science and Applications, 10(3), 125-132.

[6]. Fahn, S. (2008). The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society, 23(S3), S497-S508.

[7]. Jeong, D. H., Kim, Y. D., Song, I. U., Chung, Y. A., & Jeong, J. (2016). Wavelet energy and wavelet coherence as EEG biomarkers for the diagnosis of Parkinson's disease-related dementia and Alzheimer's disease. Entropy, 18(1), 8.

[8]. Khare, S. K., Bajaj, V., & Acharya, U. R. (2021). Detection of Parkinson's disease using automated tunable Q wavelet transform technique with EEG signals. Biocybernetics and Biomedical Engineering, 41(2), 679-689.

[9]. Liu, G., Zhang, Y., Hu, Z., Du, X., Wu, W., Xu, C., ... & Li, S. (2017). Complexity analysis of electroencephalogram dynamics in patients with Parkinson's disease. Parkinson's Disease, 2017.

[10]. Na, S. H., Song, I. U., Kim, Y. D., Cho, H. J., Chung, S. W., & Chung, Y. A. (2012). Differences of regional cerebral blood flow between early Alzheimer's disease and parkinson's disease associated with dementia on 99mtchexamethyl propylene amine oxime perfusion single photon emission computed tomography. Journal of the Korean Geriatrics Society, 16(4), 200-205.

[11]. Oh, S. L., Hagiwara, Y., Raghavendra, U., Yuvaraj, R., Arunkumar, N., Murugappan, M., & Acharya, U. R. (2020). A deep learning approach for Parkinson's disease diagnosis from EEG signals. Neural Computing and Applications, 32, 10927-10933.

[12]. Oung, Q. W., Muthusamy, H., Basah, S. N., Lee, H., & Vijean, V. (2018). Empirical wavelet transform based features for classification of Parkinson's disease severity. Journal of Medical Systems, 42, 1-17.

[13]. Oung, Q. W., Muthusamy, H., Basah, S. N., Lee, H., & Vijean, V. (2017). Empirical wavelet transform based features for classification of Parkinson's disease severity. Journal of Medical Systems, 42, 1-17.

[14]. Péron, J., Dondaine, T., Le Jeune, F., Grandjean, D., & Vérin, M. (2012). Emotional processing in Parkinson's disease: a systematic review. Movement Disorders, 27(2), 186-199.

[15]. Ruffini, G., Ibañez, D., Castellano, M., Dubreuil-Vall, L., Soria-Frisch, A., Postuma, R., ... & Montplaisir, J. (2019). Deep learning with EEG spectrograms in rapid eye movement behavior disorder. Frontiers in Neurology, 10, 806.

[16]. Song, I. U., Chung, Y. A., Chung, S. W., & Jeong, J. (2014). Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT. Dementia and Geriatric Cognitive Disorders, 37(5-6), 276-285.

[17]. Song, I. U., Kim, J. S., Yoo, J. Y., Song, H. J., & Lee, K. S. (2008). Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls. European Neurology, 59(1-2), 49-54.